Literature DB >> 12243343

Growth inhibition by connexin26 expression in cultured rodent tumor cells.

Hae-Jung Lee1, In-Kyung Lee, Kyung-Hwan Seul, Seung-Keun Rhee.   

Abstract

The Connexin (Cx) gene family acts as a tumor suppressor. However, it is unclear whether the tumor-suppressing activity acquired by Cx gene transfection is mainly due to the recovery of the gap junction-mediated intercellular communication (GJIC) or to other unknown mechanisms. In order to elucidate the mechanism of the Cx-induced tumor-suppressing activity, we transfected Cx26 cDNA into a rodent mammary tumor cell-line (BICR-M1Rk) in which Cx43 had been normally expressed and a typical pattern of GJIC had been observed. The exogenous Cx26 was mainly localized on the nuclear envelope, whereas most of the endogenous Cx43 resided at the plasma membrane of the transfected BICR-M1Rk. Consistent with the localization of Cx26, GJIC was not increased upon the transfection of Cx26 when it was assessed by a scrape-loading dye transfer technique. A conventional [3H]-thymidine incorporation study showed that the growth rate of the Cx26-transfected cells was significantly decreased (70%), compared to that of the control BICR-M1Rk. Therefore, our results clearly demonstrate that the exogenously expressed Cx26 in the BICR-M1Rk cancer cell-line exerts an anti-proliferate activity in a GJIC-independent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12243343

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  5 in total

Review 1.  Implications and challenges of connexin connections to cancer.

Authors:  Christian C Naus; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

2.  Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.

Authors:  Naomi Hokaiwado; Makoto Asamoto; Mitsuru Futakuchi; Kumiko Ogawa; Satoru Takahashi; Tomoyuki Shirai
Journal:  J Membr Biol       Date:  2007-11-03       Impact factor: 1.843

3.  Clinical significance of the expression of connexin26 in colorectal cancer.

Authors:  Shinya Nomura; Kiyoshi Maeda; Eiji Noda; Toru Inoue; Shinya Fukunaga; Hisashi Nagahara; Kosei Hirakawa
Journal:  J Exp Clin Cancer Res       Date:  2010-06-21

4.  Cx31.1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis.

Authors:  Deqiang Zhang; Chengwen Chen; Yuan Li; Xuping Fu; Yi Xie; Yao Li; Yan Huang
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

5.  Dominant negative connexin26 mutation R75W causing severe hearing loss influences normal programmed cell death in postnatal organ of Corti.

Authors:  Ayako Inoshita; Keiko Karasawa; Megumi Funakubo; Asuka Miwa; Katsuhisa Ikeda; Kazusaku Kamiya
Journal:  BMC Genet       Date:  2014-01-03       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.